MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
11.56
+0.58
+5.28%
After Hours: 11.33 -0.23 -1.99% 19:34 07/21 EDT
OPEN
11.02
PREV CLOSE
10.98
HIGH
11.78
LOW
10.79
VOLUME
403.57K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
10.03
MARKET CAP
184.28M
P/E (TTM)
-0.8060
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharma announces upcoming retirement of chief medical officer
TipRanks · 7h ago
Tonix Pharma CMO Gregory Sullivan to retire Aug. 20
PUBT · 8h ago
Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch strategy
PUBT · 1d ago
Tonix shares TNX-4800 Lyme disease prevention presentation
PUBT · 1d ago
Weekly Report: what happened at TNXP last week (0713-0717)?
Weekly Report · 1d ago
Tonix Pharmaceuticals investor deck spotlights TONMYA fibromyalgia launch and late-stage pipeline plans
PUBT · 5d ago
Tonix Pharma Announces Publication Of Monkeypox Study In Journal Of Virology, Peer-Reviewed Publication Of ASM
Benzinga · 6d ago
Tonix publishes Journal of Virology study showing 2022 mpox clade IIb up to 100,000-fold less virulent than 2003 clade IIa
PUBT · 6d ago
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.